Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px
Organisation › Details

Escalier Biosciences B.V.

Escalier Biosciences BV is a privately held biopharmaceutical company developing novel small molecule therapeutics that target ROR?t for the treatment of psoriasis and other autoimmune disorders. Escalier’s lead topical and oral drug candidates are currently in late stage preclinical studies. Escalier is registered in The Netherlands with offices in Nijmegen, The Netherlands and Encinitas, California. *


Period Start 2016-01-01 established
  Group Escalier Biosciences (Group)
Products Industry BIOTECH
  Industry 2 ROR gamma inhibitor (orphan nuclear receptor gamma inhibitor)
Persons Person Mohan, Raju (Escalier Biosciences 201803 CEO before CEO of Akarna Therapeutics)
  Person 2 Krueger, Chris (Escalier Biosciences 201803 CBO)
Region Region Nijmegen
  Country Netherlands
  Street 5J Transistorweg
  City 6534 AT Nijmegen
    Address record changed: 2018-03-17
Basic data Employees n. a.
    * Document for �About Section�: Escalier Biosciences B.V.. (3/13/18). "Press Release: Escalier Biosciences Raises $19 Million to Develop Its Topical and Systemic RORyt Therapies for Psoriasis and other Autoimmune Diseases". Nijmegen.
Record changed: 2018-10-31


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for Escalier Biosciences (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top